WorthPointe’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,515
Closed -$236K 78
2023
Q3
$236K Buy
+1,515
New +$250K 0.14% 61
2023
Q1
Sell
-2,265
Closed -$400K 57
2022
Q4
$400K Buy
2,265
+238
+12% +$41.1K 0.27% 40
2022
Q3
$331K Buy
2,027
+7
+0.3% +$1.19K 0.28% 38
2022
Q2
$358K Buy
2,020
+1
+0% +$178 0.3% 32
2022
Q1
$358K Buy
2,019
+112
+6% +$19.1K 0.29% 33
2021
Q4
$314K Buy
+1,907
New +$312K 0.28% 38

Other funds holding JNJ

WorthPointe's JNJ Position: Q4 2023 in Review

WorthPointe sold out of Johnson & Johnson (JNJ) in Q4 2023, closing a stake of 1,515 shares — an estimated $236K sold.

WorthPointe first reported a position in JNJ in Q4 2021 and held it in 6 quarters. The position peaked at $400K in Q4 2022. 3,868 funds tracked by Wall St. Rank hold JNJ as of Q4 2023.

  • WorthPointe reported no remaining Johnson & Johnson position as of Q4 2023 after selling out during the quarter.
  • WorthPointe sold 1,515 Johnson & Johnson shares in Q4 2023, an estimated $236K.
  • WorthPointe first reported a position in Johnson & Johnson in Q4 2021 and held it in 6 quarters.
  • WorthPointe's Johnson & Johnson position peaked at $400K in Q4 2022.
  • 3,868 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2023.

Based on WorthPointe's 13F filing for Q4 2023, filed 12 Feb 2024.